Literature DB >> 6218936

The relationship of human atrial cellular electrophysiology to clinical function and ultrastructure.

L Mary-Rabine, A Albert, T D Pham, A Hordof, J J Fenoglio, J R Malm, M R Rosen.   

Abstract

Although previous studies have described the electrophysiological and ultrastructural characteristics of human cardiac fibers, no attempt has been made as yet to describe quantitatively the relationship between the ultrastructural and cellular electrophysiological derangements occurring with cardiac disease, and their clinical manifestations. In this study, we used standard microelectrode techniques to record the action potential characteristics of human atrial fibers obtained during cardiac surgery and correlated the electrophysiological parameters with clinical and ultrastructural data. Ultrastructure was studied by optical and electron microscopy. We found a multiple linear regression among maximum diastolic potential, atrial size and pressure, P wave duration and ultrastructure changes. Proliferations of Z band material, widening of intercalated discs, and degenerative changes were quantified and correlated with electrophysiological and clinical data. These studies emphasize the relationship between hemodynamic anomalies and resultant changes in both human atrial fiber structure and electrical function. Finally, the likelihood of occurrence of arrhythmias can be predicted using the analytic method described.

Entities:  

Mesh:

Year:  1983        PMID: 6218936     DOI: 10.1161/01.res.52.2.188

Source DB:  PubMed          Journal:  Circ Res        ISSN: 0009-7330            Impact factor:   17.367


  27 in total

Review 1.  Mechanisms underlying the development of atrial arrhythmias in heart failure.

Authors:  Vias Markides; Nicholas S Peters
Journal:  Heart Fail Rev       Date:  2002-07       Impact factor: 4.214

2.  Autonomic modulation of the atrial cycle length by the head up tilt test: non-invasive evaluation in patients with chronic atrial fibrillation.

Authors:  M P Ingemansson; M Holm; S B Olsson
Journal:  Heart       Date:  1998-07       Impact factor: 5.994

3.  Dedifferentiation of atrial cardiomyocytes as a result of chronic atrial fibrillation.

Authors:  J Ausma; M Wijffels; G van Eys; M Koide; F Ramaekers; M Allessie; M Borgers
Journal:  Am J Pathol       Date:  1997-10       Impact factor: 4.307

4.  Structural changes in the progression of atrial fibrillation: potential role of glycogen and fibrosis as perpetuating factors.

Authors:  Ling Zhang; Bing Huang; Benjamin J Scherlag; Jerry W Ritchey; Abraham A Embi; Jialu Hu; Yuemei Hou; Sunny S Po
Journal:  Int J Clin Exp Pathol       Date:  2015-02-01

5.  Immunological and histopathological changes in the atrial tissue during and after cardiopulmonary bypass.

Authors:  N Alotti; J Sipos; E Roth; G Kecskés; J Simon; A Rashed; I Kassai
Journal:  Exp Clin Cardiol       Date:  2001

Review 6.  Cardiac Remodeling After Atrial Fibrillation Ablation.

Authors:  Li-Wei Lo; Shih-Ann Chen
Journal:  J Atr Fibrillation       Date:  2013-06-30

Review 7.  Left Atrial Fibrosis: Role in Atrial Fibrillation Pathophysiology and Treatment Outcomes.

Authors:  David Spragg
Journal:  J Atr Fibrillation       Date:  2013-04-06

8.  Modeling of arrhythmogenic automaticity induced by stretch in rat atrial myocytes.

Authors:  Jae Boum Youm; Chae Hun Leem; Yin Hua Zhang; Nari Kim; Jin Han; Yung E Earm
Journal:  Korean J Physiol Pharmacol       Date:  2008-10-31       Impact factor: 2.016

Review 9.  Making better scar: Emerging approaches for modifying mechanical and electrical properties following infarction and ablation.

Authors:  Jeffrey W Holmes; Zachary Laksman; Lior Gepstein
Journal:  Prog Biophys Mol Biol       Date:  2015-11-23       Impact factor: 3.667

10.  Metabolic syndrome and risk of development of atrial fibrillation: the Niigata preventive medicine study.

Authors:  Hiroshi Watanabe; Naohito Tanabe; Toru Watanabe; Dawood Darbar; Dan M Roden; Shigeru Sasaki; Yoshifusa Aizawa
Journal:  Circulation       Date:  2008-02-19       Impact factor: 29.690

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.